Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Protein Profiling Assays for Breast Cancer Prognosis | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Prostate Specific Antigen (PSA) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Prademagene Zamikeracel (Zevaskyn) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Pozelimab-bbfg (Veopoz) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Positron Emission Tomography (PET) for Cardiac Applications | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Polatuzumab Vedotin-piiq (Polivy) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Plasminogen, human-tvmh (Ryplazim) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Plasma Exchange | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Pivekimab Sunirine-pvzy (Decnupaz) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Photodynamic Therapy (PDT) for the Treatment of Certain Cancers | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Pharmacogenetic Testing for Pain Management | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Pertuzumab, Trastuzumab and Hyaluronidase-zzxf (Phesgo) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Pertuzumab (Perjeta); Pertuzumab-dpzb (Poherdy) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Peripheral Subcutaneous Field Stimulation for the Treatment of Pain | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Percutaneous Sacroplasty | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Percutaneous Arteriovenous Fistula (pAVF) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Treatment for Sexual Dysfunction in Males: Non-Pharmacologic | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Pemetrexed (Alimta; Pemfexy, Pemetrexed, Pemrydi RTU, Axtle) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Pegcetacoplan (Syfovre) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Sodium Thiosulfate (Pedmark) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Pasireotide (Signifor LAR) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Zopapogene Imadenovec-drba (Papzimeos) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Panitumumab (Vectibix) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Palivizumab (Synagis) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Lumasiran (Oxlumo) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Osteochondral Autografting | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Piezoelectric Sensor Analysis and Oscillating Force Delivered Vertebral Adjustment in the Evaluation and Treatment of the Spinal Column | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Orthopedic Applications of Stem Cell Therapy | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Orthognathic Surgery | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Oral Negative Pressure Therapy Devices for The Treatment of Sleep Apnea | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Orthoptic Training for the Treatment of Vision or Learning Disabilities | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Ophthalmologic Techniques for the Evaluation of Glaucoma | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Patisiran Lipid Complex (Onpattro) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Pegaspargase (Oncaspar) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Onasemnogene Abeparvovec-xioi (Zolgensma) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | OnabotulinumtoxinA (Botox) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Omalizumab Products: Omalizumab (Xolair); Omalizumab-igec (Omlyclo) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Olipudase Alfa-rpcp (Xenpozyme) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Octreotide Suspension (Sandostatin LAR Depot), Octreotide Acetate for Injectable Suspension | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Pegfilgrastim (Neulasta); Pegfilgrastim-jmdb (Fulphila); Pegfilgrastim--pbbk (Fylnetra); Pegfilgrastim- apgf (Nyvepria); Pegfilgrastim-fpgk (Stimufed); Pegfilgrastim-cbqv (Udenyca); Pegfilgrastim-bmez (Ziextenzo) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Nutritional Treatment of Inborn Errors of Metabolism | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Nusinersen (Spinraza) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Romiplostim(Nplate) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Noninvasive Imaging Techniques for Evaluation and Monitoring of Chronic Liver Diseases | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Non-invasive Positive Pressure Ventilators (In-Home Use) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Non-Contact Ultrasound Treatment for Wounds | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Nonfamilial Genetic Testing for Breast Cancer Risk Assessment | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Nivolumab/Relatlimab-rmbw (Opdualag) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Nivolumab and Hyaluronidase-nvhy (Opdivo Qvantig) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Nivolumab (Opdivo) | Metadata changed |